Price $2.00 |
Market Cap
131.3M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
4.36
|
P/S
-
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-18.9K
|
FCF
-0.3
|
|
Op. Margin
-
|
Net Margin
-
|
ROE
-56.50%
|
ROI
-
|
|
ROA
-49.70%
|
EPS Growth
-0.90%
|
Current Ratio
17.2
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Boston Scientific Corporation (BSX) | $35.82 | - | - | 50.9B | Strong Buy |
| Great Elm Group Inc (GEG) | $2.76 | - | - | 77.3M | Strong Buy |
| Harrow Health Inc (HROW) | $8.71 | - | - | 159.6M | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $4.54 | - | - | 166.4M | Strong Buy |
| American Bio Medica Corporatio (ABMC) | $0.22 | - | - | 4.7M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
